SHANGHAI, May 16, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, today announced the appointment of Vijay Karwal as Chief...
from PR Newswire: https://ift.tt/33LqKvs
No comments:
Post a Comment